Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis
- PMID: 10506581
- DOI: 10.1096/fasebj.13.13.1787
Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis
Abstract
Tissue transglutaminase (TG) is an enzyme that stabilizes the structure of tissues by covalently ligating extracellular matrix molecules. Expression and localization of TG are not well established during wound healing. We performed punch biopsy wounds on anesthetized rats and monitored the wound healing process by histological and immunohistochemical methods. The TG antigen and activity are expressed at sites of neovascularization in the provisional fibrin matrix within 24 h of wounding. Endothelial cells, macrophages, and skeletal muscle cells expressed TG throughout the healing process. The TG antigen within the wound was active in vivo based on the detection of isopeptide bonds. The TG antigen increased four- to fivefold by day 3 postwounding and was proteolytically degraded. TG expression occurred in association with TGF-beta, TNF-alpha, IL-6, and VEGF production in the wound. Recombinant TG increased vessel length density (a measure of angiogenesis) when applied topically in rat dorsal skin flap window chambers. We have established that TG is an important tissue stabilizing enzyme that is active during wound healing and can function to promote angiogenesis.
Similar articles
-
Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair.Plast Reconstr Surg. 2005 Jan;115(1):204-12. Plast Reconstr Surg. 2005. PMID: 15622252
-
Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization.Stem Cells. 2005 Nov-Dec;23(10):1571-8. doi: 10.1634/stemcells.2004-0340. Epub 2005 Aug 4. Stem Cells. 2005. PMID: 16081667
-
Expression and distribution of tissue transglutaminase in normal and injured rat cornea.Curr Eye Res. 2004 Jan;28(1):37-45. doi: 10.1076/ceyr.28.1.37.23493. Curr Eye Res. 2004. PMID: 14704912
-
Angiogenesis in wound healing.J Investig Dermatol Symp Proc. 2000 Dec;5(1):40-6. doi: 10.1046/j.1087-0024.2000.00014.x. J Investig Dermatol Symp Proc. 2000. PMID: 11147674 Review.
-
Tissue transglutaminase in normal and abnormal wound healing: review article.Amino Acids. 2004 Jul;26(4):387-404. doi: 10.1007/s00726-004-0094-4. Epub 2004 Jun 21. Amino Acids. 2004. PMID: 15290345 Review.
Cited by
-
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9023-8. doi: 10.1073/pnas.0602681103. Epub 2006 Jun 6. Proc Natl Acad Sci U S A. 2006. PMID: 16757564 Free PMC article.
-
Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.J Biol Chem. 2011 Sep 16;286(37):32220-30. doi: 10.1074/jbc.M111.255562. Epub 2011 Jul 11. J Biol Chem. 2011. PMID: 21757696 Free PMC article.
-
Transglutaminase 3 Reduces the Severity of Psoriasis in Imiquimod-Treated Mouse Skin.Int J Mol Sci. 2020 Feb 25;21(5):1566. doi: 10.3390/ijms21051566. Int J Mol Sci. 2020. PMID: 32106600 Free PMC article.
-
Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.Mol Vis. 2018 Jan 31;24:83-93. eCollection 2018. Mol Vis. 2018. PMID: 29422766 Free PMC article.
-
Facilitated wound healing by activation of the Transglutaminase 1 gene.Am J Pathol. 2000 Dec;157(6):1875-82. doi: 10.1016/S0002-9440(10)64826-2. Am J Pathol. 2000. PMID: 11106560 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
